Modifiable risk factors for vascular access site complications in the IMPACT II trial of angioplasty with versus without eptifibatide

Jeffrey S. Mandak, James C. Blankenship, Laura H. Gardner, Scott D. Berkowitz, Frank V. Aguirre, Kristina N. Sigmon, Gerald C. Timmis, Ian C. Gilchrist, Michael McIvor, Jon Resar, Bonnie H. Weiner, Barry S. George, J. David Talley, A. Michael Lincoff, James E. Tcheng, Robert M. Califf, Eric J. Topol

Research output: Contribution to journalArticlepeer-review

71 Scopus citations

Fingerprint

Dive into the research topics of 'Modifiable risk factors for vascular access site complications in the IMPACT II trial of angioplasty with versus without eptifibatide'. Together they form a unique fingerprint.

Medicine & Life Sciences